₹24,758 Cr
891.87
₹28 Cr
As on 13-Aug-2024 IST
₹0.92
•
0.50%
₹185.84
₹187.10
₹193.25
₹185.60
60,75,593
₹87.50 - 193.25
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Piramal Pharma
| 34.50 | 23.60 | 24.13 | 90.18 | -- | -- | -- |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Mid Cap
| 26.89 | -1.61 | 13.94 | 53.62 | 26.75 | 27.88 | 17.84 |
|
2023
|
|
|---|---|
|
Piramal Pharma
| 24.01 |
|
BSE Mid Cap
| 45.53 |
|
BSE Healthcare
| 36.97 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
No Review & Analysis are available.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Piramal Pharma Ltd stood at ₹ 15,312 Cr as on 30-Jun-24
The share price of Piramal Pharma Ltd is ₹186.76 (NSE) and ₹186.75 (BSE) as of 13-Aug-2024 IST. Piramal Pharma Ltd has given a return of 90.18% in the last 1 years.
Piramal Pharma Ltd has a market capitalisation of ₹ 24,758 Cr as on 13-Aug-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Piramal Pharma Ltd is 3.18 times as on 13-Aug-2024, a 26% discount to its peers’ median range of 4.29 times.
The P/E ratio of Piramal Pharma Ltd is 891.87 times as on 13-Aug-2024, a 2573% premium to its peers’ median range of 33.36 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Piramal Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Piramal Pharma Ltd.
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
The promoters of Piramal Pharma Ltd are The Sri Krishna Trust through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A Piramal and V3 Designs LLP. They collectively own 29.87 per cent of the total equity. The chairman of the company is Nandini Piramal
There is no promoter pledging in Piramal Pharma Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
41,532
|
|
|
33,841
|
|
|
25,812
|
|
|
24,740
|
| Piramal Pharma Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
1.31
|
|
Operating margin(%)
|
6.17
|
|
Net Margin(%)
|
-0.47
|
|
Dividend yield(%)
|
0.06
|
Yes, TTM profit after tax of Piramal Pharma Ltd was ₹28 Cr.
No Review & Analysis are available.
₹24,758.35 Cr
₹8,373.45 Cr
₹27.76 Cr
₹627.25 Cr
₹4,558.86 Cr
34.95%
High
₹87.50 - 193.25
₹10.00
1,32,57,48,130
BSE: 543635, NSE: PPLPHARMA
Mumbai, Maharashtra
www.piramalpharma.com
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India.... Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited. Read more
Stocks 
Piramal Pharma Ltd.
Widely used:
